English  |  正體中文  |  简体中文  |  總筆數 :2856753  
造訪人次 :  53853851    線上人數 :  1136
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"ho p y"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-10 / 30 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-03-04T03:48:21Z αB-Crystallin in clear cell renal cell carcinoma: Tumor progression and prognostic significance Ho P.-Y.; Chueh S.-C.; Chiou S.-H.; Wang S.-M.; WEI-CHOU LIN; Lee I.-L.; Yang H.-Y.; Peng H.-C.; Lai M.-K.
臺大學術典藏 2022-01-11T06:49:28Z The Development of Controllable Magnetic Driven Microphysiological System Yang J.-W.; Chen Y.-W.; Ho P.-Y.; Jiang L.; Hsieh K.Y.; Cheng S.-J.; Lin K.-C.; Lu H.-E.; HSIEN-YI CHIU; Lin S.-F.; Chen G.-Y.
國立成功大學 2022 Prevalence and household risk factors for fecal carriage of ESBL-producing, sequence type 131, and extraintestinal pathogenic Escherichia coli among children in southern Taiwan Cheng, M.-F.;Ho, P.-Y.;Wang, J.-L.;Tseng, F.-C.;Chang, J.-T.;Huang, I.-F.;Hung, C.-H.
臺大學術典藏 2021-09-01T01:53:49Z Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma Tsai Y.-C.; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; ANN-LII CHENG; Cheng J.C.-H.
臺大學術典藏 2021-08-31T06:29:51Z Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cells Tsai Y.-C.; Ho P.-Y.; Tzen K.-Y.; Tuan T.-F.; Liu W.-L.; ANN-LII CHENG; Pu Y.-S.; Cheng J.C.-H.
臺大學術典藏 2021-08-02T02:32:49Z αB-Crystallin in clear cell renal cell carcinoma: Tumor progression and prognostic significance Ho P.-Y.; SHIH-CHIEH CHUEH; Chiou S.-H.; Wang S.-M.; Lin W.-C.; Lee I.-L.; Yang H.-Y.; Peng H.-C.; Lai M.-K.
臺大學術典藏 2021-07-08T01:23:59Z In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53-associated cell cycle arrest Lee W.-S.; Chen R.-J.; Wang Y.-J.; Tseng H.; JIIANG-HUEI JENG; Lin S.-Y.; Liang Y.-C.; Chen C.-H.; Lin C.-H.; Lin J.-K.; Ho P.-Y.; Chu J.-S.; Ho W.-L.; Chen L.-C.; Ho Y.-S.
臺大學術典藏 2021-03-18T05:59:06Z Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma Tsai Y.-C.; Yeh C.-H.; KAI-YUAN TZEN; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; Cheng A.-L.; Cheng J.C.-H.
臺大學術典藏 2021-03-18T05:59:01Z Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cells Tsai Y.-C.; Ho P.-Y.; KAI-YUAN TZEN; Tuan T.-F.; Liu W.-L.; Cheng A.-L.; Pu Y.-S.; Cheng J.C.-H.
臺大學術典藏 2021-03-04T02:35:59Z Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma Yu-Chieh Tsai;Yeh C.-H.;Tzen K.-Y.;Ho P.-Y.;Tuan T.-F.;Pu Y.-S.;Cheng A.-L.;Cheng J.C.-H.; YU-CHIEH TSAI; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; Cheng A.-L.; Cheng J.C.-H.

顯示項目 1-10 / 30 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目